Aurobindo Pharma hives off its biosimilars business to subsidiary CuraTeQ Biologics
Aurobindo Pharma hives off its biosimilars business to wholy-owned subsidiary ‘CuraTeQ Biologics Private Limited’ for a cash consideration of ₹361.46 crore. The... Read More
Lupin, Mylan receive EUmarketing authorization for Nepexto
Lupin Limited (Lupin) and Mylan N.V. announced that the European Commission (EC) has granted marketing authorization for Nepexto, a biosimilar to Enbrel... Read More
AstraZeneca, Accent Therapeutics partners to develop transformative therapeutics targeting RMPs to treat cancer
Accent Therapeutics and AstraZeneca forged a collaboration valued at about $1.1 billion to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins... Read More
Roche’s Elecsys IL-6 test received USFDA EUA
Roche announced that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorisation (EUA) for the Elecsys IL-6 test.... Read More